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Finding and characterizing mRNAs, their transcription start sites (TSS), and their associated promoters is a major focus in
post-genome biology. Mammalian cells have at least 5–10 magnitudes more TSS than previously believed, and deeper
sequencing is necessary to detect all active promoters in a given tissue. Here, we present a new method for high-
throughput sequencing of 59 cDNA tags—DeepCAGE: merging the Cap Analysis of Gene Expression method with ultra-
high-throughput sequence technology. We apply DeepCAGE to characterize 1.4 million sequenced TSS from mouse
hippocampus and reveal a wealth of novel core promoters that are preferentially used in hippocampus: This is the most
comprehensive promoter data set for any tissue to date. Using these data, we present evidence indicating a key role for the
Arnt2 transcription factor in hippocampus gene regulation. DeepCAGE can also detect promoters used only in a small
subset of cells within the complex tissue.
[Supplemental material is available online at www.genome.org. CAGE tag sequences have been submitted to the DNA
Data Bank of Japan (http://www.ddbj.nig.ac.jp/) under accession nos. AGAAA0000001–AGAAA0552486. Processed
CAGE data sets are freely available at http://people.binf.ku.dk/albin/supplementary_data/hcamp/.]
Transcription initiation is one of the most fundamental cellular
processes. The identification of transcription start sites (TSS) leads
to the detection of the associated core promoters. Historically,
precise definition of TSS has been laborious and addressed one
gene at a time. Therefore, few genes have had their start sites
mapped in detail. We, and others, have presented techniques that
can identify TSS on a genome-wide scale—typically, by generating
full-length cDNAs and then sequencing short tags at their 59 ends
(Ng et al. 2005; Kodzius et al. 2006). The largest study to date using
such methods (Carninci et al. 2006) was carried out by taking
advantage of the cap analysis of gene expression (CAGE) tech-
nology (Kodzius et al. 2006). In the FANTOM3 project, tag libraries
were sequenced from 22 tissues with an average ;48,500 tags per
library in mouse. This study gave new insights into how tran-
scription initiationworks, as reviewed (Muller et al. 2007; Sandelin
et al. 2007), and suggested that mammalian cells have many more
core promoters than previously appreciated. In a previous study
(Gustincich et al. 2006), we have also shown that mouse brain
regions have a higher number of active TSS than other tissues,
presumably leading to a higher diversity of distinct transcripts in
these tissues. Since the average mammalian cell is estimated to
express at least 350,000mRNAs (Jackson et al. 2000) and the brain
is a highly complex tissue with many distinct regions, which in
themselves have high cellular heterogeneity, it is evident that the
promoters sampled so far are just skimming the surface of the
brain transcriptional complexity.
Among the different regions of the brain, the hippocampal
formation (hippocampus, dentate gyrus, and subiculum) has been
the subject of intense studies due to its essential role in the for-
mation of new episodic and long-termmemories (Bird and Burgess
2008). In particular, the hippocampus has been a major experi-
mental system to unveil the role of synaptic plasticity. The hip-
pocampus has also been implicated in a number of neurological
and psychiatric disorders including epilepsy and Alzheimer’s dis-
ease. Additionally, the subgranular zone of the dentate gyrus is one
of the sites of adult neurogenesis (Zhao et al. 2008).
The study of the hippocampal formation has relied on its
distinctive and readily identifiable structure at both gross and
histological levels (Paxinos 2004). The hippocampus is divided
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into fields CA1–CA3 comprising the pyramidal cell layer, where
the pyramidal cells are present, and a heterogeneous group of di-
verse GABAergic interneurons (Parra et al. 1998; Maccaferri and
Lacaille 2003). The dentate gyrus comprises the molecular, prin-
cipal, and polymorphic layers where the granule cells are the
principal cells and the pyramidal basket cells are the most prom-
inent class of interneurons. In a few cases, the use of cell-type-
specific knockout mice for ligands or receptors of neuroactive
molecules has made it possible to integrate physiological, ana-
tomical, and molecular data from synapses to understand animal
behavior (Tsien et al. 1996; Nakazawa et al. 2004). However, our
understanding of the physiological organization of the hippo-
campus has been hampered by difficulties in describing the
complete repertoire of neuronal cell types and their properties
(Parra et al. 1998).
Thus, the identification of specific promoters that initiate
transcription and drive gene expression in hippocampus, or even
in specific subsets of cells within the tissue, will be important for
developing new lines of mice with cell- or tissue-specific gene
isoforms labeled and/or knocked out, or by the use of neuronal cell
ablation (Watanabe et al. 1998; Tonegawa et al. 2003). The iden-
tification of novel promoters, particularly those that drive ex-
pression in a small number of neurons, may also lead to the
description of rare neuronal types that have not been previously
characterized.
To this end, we present DeepCAGE, a method combining
CAGE technology with a high-throughput tag sequencer, the GS20
sequencer (454 Life Sciences [Roche]). We use DeepCAGE to create
a comprehensive resource of hippocampal TSS and core promoters.
Since with this method we can reach an unprecedented sampling
depth (2 million tags, of which 1.4 million can be unambiguously
mapped to the genome), we explored this data set to find promoters
preferentially used in the hippocampus, their effects on the pro-
teome, correlation with spatial expression data, and to understand
the transcriptional regulatory program in the hippocampus.
Results
DeepCAGE sequencing
We adapted the CAGE method (Shiraki et al. 2003; Kodzius et al.
2006) to the 454 Life Sciences (Roche) GS20 sequencer as de-
scribed inMethods (Fig. 1). Briefly, total RNA fromC57B6/J pooled
mice hippocampi was purified and used as a template in the first-
strand cDNA reaction primed by random primers to capture both
the poly(A)+ and poly(A) RNA species. To extend cDNA synthesis
through GC-rich regions in the 59 UTR, we carried out the reverse
transcription reaction at high temperature in the presence of tre-
halose and sorbitol (Carninci et al. 2002). cDNAs reaching the cap
site were then selected by cap-trapping. They were then ligated to
a linker having a recognition site for the class-IIs restriction en-
donucleaseMmeI just next to the start of the cDNAs corresponding
to the 59-end of the original RNAs. This linker was used to prime
second-strand cDNA synthesis. Subsequently, MmeI digestion
cleaved 20 ; 21 bp within the double-stranded cDNA, releasing
CAGE tags. After ligation of a second linker to the 39 end opened
by MmeI digestion, CAGE tags were PCR amplified, purified, and
further amplified before restriction and concatenation for direct
sequencing (see Methods). The DeepCAGE technology does not
require cloning in bacteria.
The key step for direct sequencing on the 454 device is the
introduction of specific primer sites at the ends of the concatamers
by mixing the CAGE tags at a ratio of 20:1 with a mixture of the
454 linkers ‘‘A’’ and ‘‘B.’’ Since these linkers (Margulies et al. 2005)
can ligate DNA only on one side, they terminate the concatena-
tion reaction and provide ends suitable for sequencing when A
and B appear on the opposite sides of the concatamer, regardless of
the orientation of the CAGE tags and insert size, which was opti-
mized to be ;500 bp.
After a first test run, we produced two large-scale reactions,
achieving in total ;2 3 106 CAGE tags. After sequencing, tags
were mapped to the mouse genome (mm8 assembly) using an
algorithm based on our previous studies (see Methods); in total,
1.4 3 106 tags map with high stringency (see Supplemental Table
S1). The samemapping protocol was applied to all other CAGE tag
libraries that are part of the data set used in this study. All CAGE
tags have been submitted to the DNA Data Bank of Japan (DDBJ)
under accession numbers AGAAA0000001–AGAAA0552486.
Data sets and resource preparation
Similar tomost other high-throughput genomic technologies (The
ENCODE Consortium 2007), CAGE data are most useful together
with other data sets. In this study, we compare the hippocampus
CAGE data to seven other CAGE data sets—each corresponding to
a different tissue—with varying sequencing depth, including three
brain tissues: visual cortex, somatosensory cortex, and cerebellum
(see Supplemental Table S1). We also use the FANTOM3 cDNA set for
associating promoters with genes and gene annotation (Carninci
et al. 2005). As a resource for the community, the CAGE data sets
(including ‘‘tissue-specific’’ promoter sets discussed below) pre-
pared here are freely available as data tracks and sequence files at
http://people.binf.ku.dk/albin/supplementary_data/hcamp/,
fromwhere they can be directly uploaded to the UCSC browser for
visualization, or downloaded for analysis by power users. Addi-
tional statistics such as the fraction of tags mapping to known 59-
ends are shown in Supplemental Figure S1.
Exploration of tissue preferences for core promoters
As shown previously, for analysis of core promoters, it is helpful to
group CAGE tags that map close to each other on the genome.
Using the method of Carninci et al. (2006), tags from any tissue
were grouped into a tag cluster if their genome mapping coor-
dinates overlap on the same strand.
To explore the overall tissue preference of the CAGE clusters,
we selected all CAGE tag clusters that have more than 30 tags per
million (TPM), when counting all tissues. For clarity, TPM nor-
malization is commonly used in tag-based studies and can be de-
scribed as normalizing all tag counts so that the total count of
mapped tags within a library equals 106 tags. The reason for this
conservative cutoff is that a certain number of tags are needed to
assess tissue distributions. For simplicity, we refer to these clusters
as core promoters in this study, in the same way as in Carninci
et al. (2006) and Sandelin et al. (2007).
This analysis identified 18,948 core promoters. To explore
both what fraction of promoters are expressed primarily in one or
a subset of tissues and what tissues have similar promoter usage,
we hierarchically clustered these core promoters in terms of their
expression and visualized the results as a heatmap (Fig. 2A; Eisen
et al. 1998). We observe that:
1. The brain tissues cluster together in terms of promoter usage; in
particular, visual and somatosensory have the most similar
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usage, with few CAGE tag clusters being preferentially used in
only one of these tissues.
2. The cortex tissues have substantial ‘‘smearing.’’ Many pro-
moters are used, but they are also shared between at least two
tissues. This is a property seen also for macrophage and lung
tissues, whichmight be due to the large number of macrophage
cells present in lung tissue.
3. Conversely, there is a large set of promoters that are used mostly
in the hippocampus: This promoter set has very little smearing,
a feature shared with less complex tissues such as liver. The
cerebellum is somewhere in between the hippocampus and the
cortex tissues in terms of smearing and specificity.
Note that this analysis only captures general properties of the
sets—there are always individual exceptions to any ‘‘rules’’ im-
plied, but the goal is to see the overall tendencies. The results from
this data exploration suggest that both the hippocampus and
cerebellum have more core promoters that are biased toward the
tissue in question than other sampled brain tissues. We explore
these in the next section.
Definition of preferentially expressed promoters
We then identified the core promoters that are significantly biased
toward individual tissues. Historically, in molecular biology liter-
ature, promoters with this property are often called tissue specific:
We will avoid this term here since it implies exclusive expression
in a given tissue, which is impossible to ascertain since we cannot
sample all tissues with infinite depth. We can only assess the
properties of the tissues sampled, and the goal is to find tag clusters
that are preferentially used in one of the
sampled set of tissues compared to the
rest of tissues. We refer to such clusters
as preferentially expressed promoters
(PEPs), used in the following context: A
liver PEP is a promoter that is preferen-
tially used in liver tissue. We term a core
promoter preferentially expressed for
a certain tissue if (1) the number of tags
from this tissue is greater than the sum of
all other tags from other tissues, nor-
malized for library size; and (2) this
overrepresentation is statistically signifi-
cant (see Methods).
Using this method, out of the
18,948 core promoters assessed, 6536
(34%) are preferentially used in a single
tissue. Hippocampus, cerebellum, and
liver have themost PEPs, while visual and
somatosensory cortex have the fewest
(Fig. 2B). Interestingly, only 8% of the
hippocampus PEPs analyzed have only
hippocampus tags, although this fraction
is dependent on the expression cutoff (30
TPMs) used in the selection of tag clusters
to start with: Smaller cutoffs give larger
number promoters only detected in hip-
pocampus (Supplemental Fig. S2).
As noted previously (Gustincich
et al. 2006), promoters used preferen-
tially in brain generally have multiple
TSS and higher CpG content compared
to promoters used preferentially in other tissues, which often have
a single peak distribution of TSS, governed by a TATA-box (San-
delin et al. 2007). We found that hippocampus PEPs share the
properties of the other brain PEPs in this regard—broader, CpG-
rich promoters with fewer TATA patterns (Supplemental Figs. S3–
S5).We also note that for promoters that are used strongly inmany
brain tissues, the hippocampus tag usage at the nucleotide level
generally correlates well with tag distributions from the other
brain tissues (Supplemental Figs. S6 and S7). There are exceptions
to this; promoters where the tag distribution shape differs between
tissues have been explored previously by Kawaji et al. (2006).
We then assessed where the PEPs from the various tissues
were located in terms of overlap with known genes (see Methods).
Figure 2B shows that the hippocampus, apart from having the
largest amount of PEPs overall, also has the greatest number of
PEPs located in intronic and intergenic space. This indicates that
there are many strong promoters preferentially expressed in the
hippocampus that have no known corresponding gene. This ob-
servation is not simply a sample size effect, as the cerebellum has
almost as many PEPs with just ;18% of the sequencing depth
compared to the hippocampus.
RACE validates distal upstream promoters
While PEPs falling within genes can be considered candidate al-
ternative promoters for the same gene, PEPs in intergenic space are
more likely to be the promoters of novel transcripts. We selected
10 intergenic hippocampus PEPs for RACE validation. Impor-
tantly, the selection was not in any way based on additional
information that would be a validation in itself, such as EST
Figure 1. Preparation of DeepCAGE cDNA libraries. cDNA is produced with reverse transcriptase
using random priming to maximize chances to reach the cap sites and to include non-polyadenylated
RNAs. The cap site is biotinylated, followed by cleavage of single-strand RNA (incomplete cDNA). After
recovery of the cDNA, a linker is ligated on the 59-end, which carries the MmeI restriction site, which
cleaves 20/21 nt inside the 59-end of the cDNA. After a second linker ligation and PCR amplification,
restricted digested tags are purified and finally concatenated together with the ‘‘454’’ linkers A and B.
(SMB) Streptavidin-coated magnetic beads; (B) biotin.
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sequences. Out of the 10 cases, eight had a PCR product, and the
sequenced product validated a hippocampus PEPs in six of these
cases. Of the failed cases, one had supporting evidence from other
sources (overlap of 59-ends of spliced ESTs) (data not shown). The
outcome is comparable to that of RACE validation of intergenic
transcribed regions from tiling array data in the ENCODE project
(50%–70% success rate) (The ENCODE Project Consortium 2007);
however, this should not be viewed as a true sensitivity measure of
Figure 2. (Legend on next page)
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DeepCAGE, for three principal reasons: (1) Even in perfect cir-
cumstances, RACE does not have perfect sensitivity; (2) as we are
focusing on novel core promoters, we do not know the exon
structure of the downstream product, which makes primer design
nontrivial; and (3) many of the promoters have high GC content,
which makes amplification challenging. Nevertheless, these
results show that promoters inferred by DeepCAGE can be detec-
ted by other methods, as already shown previously in extensive
validation experiments of the original FANTOM3CAGE study (see
Supplemental Material of Carninci et al. 2006).
In the annotation process, we noticed a considerable number
of cases in which intergenic hippocampus PEPs were located rel-
atively close to the 59-end of a known gene. These cases are likely
novel alternative upstream promoters. An example is shown in
Figure 2C: CAGE and RACE data show a novel hippocampus PEP
upstream of the mouse Bai3 (brain-specific angiogenesis inhibitor
3) gene. An extreme case is shown in Figure 2D: CAGE identifies
a hippocampus PEP that is upstream of the Arpc5 (actin-related
protein 2/3 complex, subunit 5) gene, but on the other strand,
forming a bidirectional promoter. RACE validation as well as hu-
man orthologous transcripts and EST evidence show that the
novel promoter is likely a distal upstream alternative promoter of
the Rgl1 (ral guanine nucleotide dissociation stimulator-like 1)
gene, whose RefSeq-annotated start site (which is also a hippo-
campus PEP) (data not shown) is a remarkable ;141 kb down-
stream from the novel promoter. Therefore, while we focused on
intergenic promoters to find novel transcripts, we often identified
novel promoters that provide new ways to regulate the transcrip-
tion of known genes.
Brain tissues use different alternative promoters
within the same gene
As shown in Figure 2B, the majority of hippocampus PEPs are lo-
cated inside genes, overlapping annotated exons. It is likely that
many of these are alternative promoters for the same gene, since
many of them are supported by full-length cDNAs (see examples
in Figs. 3 and 4). Alternative promoters are interesting for three
reasons: (1) They allow a gene to have multiple, distinct, regula-
tory inputs; (2) alternative promoter locations can affect the pro-
tein content of the gene product similarly to alternative splicing;
and (3) it is important for molecular approaches in neurobiology
to selectively knock down gene isoforms that are preferentially
used in a given tissue.
We first identified all genes containing one or more PEPs
from hippocampus, somatosensory cortex, visual cortex, and
cerebellum inside exons. Then, we counted the number of genes
withmultiple distinct PEPs from the different tissues (Fig. 3A). The
Dlgap1 gene (guanylate kinase-associated protein [GKAP] or SAPAP
[synapse-associated protein 90-postsynaptic density-95-associated
protein]) (Fig. 3B) is exceptional since it has four core promoters
that are preferentially used in hippocampus, somatosensory cor-
tex, visual cortex, and cerebellum, respectively. All of these PEPs
overlap corresponding 59-ends from full-length cDNAs (Fig. 3B); in
this case, the CAGE verifies these 59-ends and assigns tissue ex-
pression constraints. Dlgap1 is a scaffolding postsynaptic density
protein at excitatory synapsis that contains 14-amino-acid repeats
at the N terminus involved in protein–protein interactions and
that are affected by different promoter usage (Kim et al. 1997;
Romorini et al. 2004); the CAGE data indicate that all the PEPs are
upstream of these repeats except for the cerebellum, indicating
that cerebellum transcripts do not include the repeats. Thus, the
selection of alternative promoters has in this case a clear func-
tional consequence.
We then sought to systematically identify potential changes
in protein domain composition caused by usage of hippocampus
PEPs. Using cDNA data, we predicted protein domains to genomic
positions and determined in how many cases a hippocampus PEP
falls within a gene but downstream from a protein domain within
the same gene, which then would give a protein product that is
lacking the domain in question. Using conservative criteria (see
Methods), we found 50 such genes (see Supplemental Material).
Three examples (Pclo, Bai1, andMyo10), showing dramatic protein
domain content diversity, are shown in Figure 4.
Transcription factor binding sites analysis on specific
core promoters
An advantage with the CAGE is that tags give high-resolution
mappings of active TSS, which can be used to pinpoint core pro-
moters for computational sequence analyses (Wasserman and
Sandelin 2004). We first analyzed the 1000 to +200 region sur-
rounding PEPs from the tissues in Supplemental Table S1 for sig-
nificantly overrepresented motif matches from the JASPAR
database (Vlieghe et al. 2006). Our results are largely consistent
with previous studies of promoters used primarily in single tissues—
for instance, homeobox motifs are overrepresented in embryo
PEPS, ETS motifs in macrophage PEPs, and so on (Supplemental
Tables S3 and S4). Since CAGE data may also be interpreted as
promoter usage (the number of tags mapped to a loci), we in-
vestigated what transcription factor genes are strongly expressed
in hippocampus, and whether their predicted transcription factor
binding sites have a clear preference to the promoters that are
preferentially used in the same tissue.
Figure 5A plots the fraction of hippocampus tags in tran-
scription factor genes compared to other tissues versus the overall
hippocampus expression of the same genes (CAGE TPMs) (see
Methods). Only a handful of transcription factor genes stand
out as very highly expressed in hippocampus, including Arnt2,
Sp3, and Aes, and only some of these have a clear preference for
Figure 2. Exploration and validation of identified core promoters. (A) Exploration of tissue usage in all core promoters having more than 30 tags per
million using hierarchical clustering, with CAGE tag expression data from the actual core promoters. Preferential usage for a certain tissue (fraction of tags
belonging to the tissue in question) is color-coded as shown in the legend. Rows represent individual promoters (the row dendrogram is omitted because
of the large number of rows), while columns are the different tissues. (B) Number of core promoters used preferentially in just one tissue (PEPs, as defined
in Methods) and the locations of these core promoters relative to known genes. (C,D) Examples of discovery and validation of novel intergenic promoters
expressed preferentially in hippocampus. All hippocampus tags are shown as red bar plots (one for each strand). Clusters of tags that are preferentially
expressed in hippocampus (hippocampus PEPs) are shown as blue fragments where the color intensity is proportional to the fraction of tags in the cluster
from hippocampus vs. other tissues. RACE products are in black. (C) The validation of a proximal alternative promoter to the Bai3 gene. (D) The validation
of a promoter upstream of the Arpc5 gene but on the opposite strand; RACE as well as a human orthologous transcript show that this is a distal upstream
promoter for the Rgl1 gene.
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hippocampus. We compared these highly expressed transcription
factors with mouse in situ hybridization experiments from the
Allen Brain Atlas (Lein et al. 2007, see image 5B-I). Overall, there is
a high correspondence between both preferential expression in
hippocampus and overall strength of expression between CAGE
and the in situ hybridization data. The general pattern is that in
situ data show high correlation with the CAGE data if the number
of CAGE tags is high, while the gene is sometimes not visibly
expressed in situ if the CAGE tag count is low; this is likely because
a certain number of transcripts are necessary to get a visible signal
in in situ hybridization, whereas CAGE technology may sample
smaller numbers of transcripts in a cell.
For most of the highly expressed
transcription factors, we have no corre-
sponding computational model for how
they bind DNA. However, since many
transcription factors from the same struc-
tural class bind similar target sequences
(Sandelin and Wasserman 2004), ob-
served overrepresentation of hits with
a given model might be due to binding
sites from a different factor with similar
binding preferences. As an example, the
predicted sites for the well-studied bHLH-
PAS Arnt gene are overrepresented in
hippocampus PEPs (Supplemental Table
S3), but the Arnt gene is lowly expressed
in the whole brain as measured by both
CAGE and in situ data (data not shown).
Interestingly, its paralog Arnt2 is primar-
ily expressed in brain. According to the
CAGE data, Arnt2 is highly, and prefer-
entially, expressed in hippocampus (Fig.
5A). Furthermore, in situ images of Arnt2
confirm a distinctive expression of Arnt2
in the C1 region of the hippocampus
(Fig. 5B). This leads to the hypothesis
that the Arnt predicted sites are, in fact,
sites for Arnt2, which would make Arnt2
a major factor in hippocampus tran-
scription regulation.
Promoters used in restricted cell types
in hippocampus
We have focused above on relatively
strong promoters having more than 30
TPMs in order to study the distribution of
tags fromdifferent tissues in a statistically
valid way. The significance of transcripts
that are present in a tissue with low
frequency has been met with suspicion,
and the observations were often labeled
either as methodological or transcrip-
tional noise. Although both of these
are still a possibility, we have explored
the expression properties of known
genes having substantially less than 30
TPMby analyzing their spatial expression
patters using in situ hybridization data.
In Figure 6, we compare the number of
tags hitting a known gene and the cor-
responding in situ images. Note that in almost all these cases, the
tags hit the annotated 59-end of the gene (Supplemental Fig. S8).
From Figure 6, we note that rare tags frequently identify
genes whose expression is restricted only to a reduced and well-
defined cell population within the tissue, whichmay have specific
physiological roles. Within these cells, the gene is highly expressed,
but since the CAGE experiment is performed on all the cells in the
tissue, the total signal is averagedout.Developmentofnext-generation
technologies to prepare CAGE libraries from individual neuronal
populations will further address this variability. Nevertheless, the
ability of DeepCAGE to detect transcripts used in only a handful
of cells in a complex tissue shows the utility of the method.
Figure 3. Alternative promoters preferentially expressed in different brain tissues. (A) The Venn di-
agram shows the number of genes having at least one preferentially expressed promoter (PEP) from any
of the four sampled brain tissues, or any combination PEPs of the four tissues. For example, there are 15
genes that have at least one hippocampus PEP and one cerebellum PEP. (B) The Dlgap1 gene has four
PEPs, one from each brain tissue. All of these are overlapping known 59-ends inferred by cDNAs. There
are five 14-amino-acid-long repeats in the N-terminal end of the corresponding protein that affects the
ability to interact with other proteins. Repeats are indicated as triangles. Note that the cerebellum PEP is
downstream from these and will give a protein that lacks these repeats.
Valen et al.
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Discussion
We are on the verge of a new era, in which sequencing technology
can be used to infer biological function on a comprehensive scale,
and the power of sequencing centers will be available to normal
laboratories. Here, we have modified the CAGE protocol for the
454 Life Science instrument and demonstrate the usefulness of
deep sequencing to discover new promoters in complex tissues.
We have identified a large number of core promoters that are
preferentially used within hippocampus. Our results indicate that
of the tissues we tested, the hippocampus has the largest number
of such promoters, closely followed by cerebellum. These results
may be due to two different factors: cell type diversity of the tissue
and sequencing depth. The cerebellum is one of the least complex
among brain tissues, while the hippocampus and the cortex tis-
sues are very complex, with a plethora of different cell types. This
is also shown in Figure 6, where it is evident that small, distinct
cell populations within the hippocampus express a given gene,
while most other cells do not. The methods we use to measure
transcription cannot quantitatively measure the diversity of cells
within a tissue and consequently neither the transcription dynamics
within single cells. This strongly motivates further developments
to assess the expression rates of genes within smaller cell pop-
ulations. Such approaches in combination with the in situ data
Figure 4. Examples of changes of domain content for genes by use of hippocampus PEPs. Hippocampus preferentially expressed promoter (PEP)
locations are shown as red triangles. Locations of predicted protein domains are shown as colored blocks (note that domains spanning more than exons
are extended over the intron(s). In all of these cases, at least one domain is upstream of the PEP, which means that this domain is not included in the
isoform expressed in hippocampus. Known cDNA locations are shown below: transcription is right-to-left. BAI1 is a membrane protein whose N-terminal
domain is extracellular, with a transmembrane region just downstream from the GPS domain (data not shown). The extracellular part can be cleaved off
at the GPS domain, releasing a tumor-suppressing peptide; however, the hippocampus PEP is just downstream from the GPS domain, presumably giving
a BAI1 variant that is attached to the membrane but without the extracellular domains, which lack the tumor-suppression capability (Kaur et al. 2005).
Similarly, the PEPs inMyo10 confirm a previous study showing the neuronal expression of an isoform lacking theMyosin head domain (Sousa et al. 2006).
In Pclo, the zf-piccolo domain cannot be included when using the hippocampus PEP.
Analysis of hippocampus promoters using DeepCAGE
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from the Allen Brain Atlas may result in a newmolecular taxonomy
of the different types of hippocampal cells providing a framework
for a complete description of the components of hippocampal cell’s
network (Gray et al. 2004; Ma 2006; Sugino et al. 2006).
The subset of novel hippocampus promoters that are not
overlapping known transcripts could indicate noncoding RNAs
that have as yet not been sampled in mouse; Mercer et al. (2008)
showed the existence of other long noncoding RNAs that are
expressed primarily in brain. On the other hand, we also find that
many of the ‘‘novel’’ promoters, in fact, are new upstream pro-
moters for known genes.
However, most of these novel promoters fall within known
genes, and we find that many genes have different core promoters
that are used preferentially by different brain tissues, which may
give partially different RNAs and protein products. In extension,
identification of cell-type-specific alternative promoters for genes
encoding for proteins responsible for neuronal and synaptic ac-
tivity (channels, receptors, etc.) may provide increased specificity
for drug treatments for epilepsy and other hippocampal-related
neuropsychiatric disorders. Although this approach may seem far
from our current technology, the use of antigene RNAs (agRNA) or
peptide nucleic acids (agPNA) as well as of Locked Nucleic Acids
(LNA) that target specific promoters has been proposed and
demonstrated in vitro ( Janowski et al. 2005a,b). This is particularly
relevant since new promising strategies for delivery of nucleic-
acid-based modifiers of gene expression into the brain have been
Figure 5. Transcription factor genes with preferential expression in hippocampus. (A) The relation between expression strength (number of hippo-
campus CAGE tags/million) vs. the ‘‘tissue specificity’’ (fraction of hippocampus tags vs. all brain tags, normalized for library size) of all known tran-
scription factor genes. Note that only a few transcription factor genes are both highly expressed in and highly specific for hippocampus. For example,
both in situ hybridization and CAGE data show that the Nr3c2 gene (the mineralocorticoid receptor) is not highly expressed in brain, but almost
exclusively expressed in hippocampus, while the Aes gene is expressed in the whole brain with a preference for hippocampus. (C-H and Aes, right) In situ
images for some of these factors. (B) In situ hybridization images (Lein et al. 2007) showing the hippocampus expression of the Arnt2 gene. The three
images show the Allen reference atlas, the ISH in situ image, and corresponding expression heatmaps.
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recently proven (Kumar et al. 2007). To this end, the data set we
present here, enabled by DeepCAGE, is to date the most compre-
hensive brain-centric promoter-exploration resource.
Methods
Preparation and sequencing of CAGE libraries
The preparation of the CAGE library is adapted from Shiraki et al.
(2003) and Kodzius et al. (2006), to work with the 454 Life
Sciences sequencer. The schema is represented in Figure 1. A de-
tailed protocol of the CAGE library preparation, starting from
trizol-extracted RNAs, is available in the Supplemental Material.
Once the CAGE library is prepared, we test various ratios of
beads to CAGE library ratios, using usually an excess of DNA over
beads (1:4 to 1:16 ratio beads:DNA) in the 454 GS20 protocol.
During the calibration of the instrument, small-scale runs (1/8 of
small kit runs) are used to calibrate the best DNA/beads ratio,
followed by one or more runs of 454 large-scale sequencing kits
(further details at http://www.454.com/).
In silico mapping of CAGE tags
Sequenced tags CAGE tags were mapped to mouse chromosomes
and the mitochondrial genome (Genome build: mm8) using the
BLAST/Vmatch alignment programs, and the longest full-matched
(meaning no mismatches in the middle) positions were selected.
These tags were referred to as ‘‘single-mapped’’ tags. Tags that
map to multiple locations on the genome (with the same length)
were called ‘‘multi-mapped,’’ and tags that did not map (mapped
<18 bp long) were called ‘‘unmapped.’’ These multi-mapped
and unmapped tags were passed to the rescue stage to increase
the number of ‘‘single-mapped’’ tags (see Supplemental Material),
since many promoters share identical subsequences (Faulkner
et al. 2008). Rescued tags were incorporated into the single-map-
ped tag collection, and other tags were discarded. In the rest of the
analysis, we use only the single-mapped tags; note that the same
mapping procedure was applied to all CAGE libraries in the study.
Mouse hippocampus RNA preparation and 59-RACE PCR
validation of target intergenic core promoters
Adult C57/Bl wild-type mice (n = 5) were sacrificed by CO2 in-
halation, and hippocampal regions were rapidly dissected and
snap-frozen in liquid nitrogen. Total RNA was extracted with
TRIzol reagent (Invitrogen) following themanufacturer’s protocol;
the RNA sample was treated with DNase (Ambion), aliquoted in
RNase free LoBind tubes (Eppendorf), and stored at 80°C.
RACE-ready cDNA was obtained with the Generacer kit
(Invitrogen) following the manufacturer’s protocol with no mod-
ifications starting from 5 mg of hippocampus total RNA. 59-RACE
was carried out using Platinum Taq DNA polymerase High Fidelity
(Invitrogen); each PCR product was cloned in a TOPO TA vector
(Invitrogen) and transformed in OneShot Top10 chemically
competent Escherichia coli cells. Five colonies from each plate were
selected for growth, DNA extraction (DNAMini Kit; QIAGEN), and
sequencing.
Figure 6. CAGE identifies promoter activity from small subpopulations of hippocampal cells. Examples of correspondence between CAGE tags and
signal detected by in situ hybridization, ordered from relatively high expression (from the top left quadrant), expressed as the number of CAGE tags from
hippocampus mapping to the gene, to low expression (the lowest right quadrant). On the left the original in situ signal is shown; on the right the in situ
hybridization signal is quantified with pseudo-colors where red corresponds to high expression. In situ hybridization images were obtained from the Allen
Brain Institute (Lein et al. 2007). Notice that the signal or tags corresponding to less than 5/1.43 106mapped tags correspond to RNAs that are expressed
only in a specific subset of cells.
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Oligonucleotide primers for the validation of intergenic core
promoters were hand-designed according to guidelines from the
Generacer kit manual and checked with PerlPrimer for possible
primer-dimer formation. Primers used to validate the core pro-
moters are shown in Supplemental Table S1.
Generation of tag clusters
A tag cluster (TC) was defined as themaximum set of tags where all
59-ends are <20 bp from the closest neighbor, and on the same
strand. We chose 20 bp because it is approximately the length of
a CAGE tag, and thus we know with certainty that the transcript
starting at the tag’s 59-end at least spans this region. This is the
same definition as used in Carninci et al. (2006).
Exploration of tissue preferences of tag clusters
We first normalized the expression of each TC to TPMs for each
tissue:
nc;i = rc;i 3 10
6

ri
nc = +inc;i
where rc,j is the number of non-normalized tags in cluster c for
tissue i, ri is the total number of non-normalized tags for tissue i,
and nc is the total TPM for the cluster. Only TCs with nc >30 TPM
were considered. We then normalized the total expression of each
such tag cluster to sum to 1:
tc;i =nc;i

nc
where tc,i is the normalized contribution of tissue i to cluster c. We
then hierarchically clustered the set of promoters in terms of ex-
pression in each tissue (the tc,i values) using Euclidian distance
measure and complete linkage as the clustering method (the
defaults of the dist() and hclust() functions in R, respectively). The
reordering of columns (tissues) and rows (tag clusters) was visu-
alized using the heatmap.2() function in the gplots R package.
Generation of preferentially expressed promoters (PEPs)
To call a TC c preferentially expressed in a tissue i, we considered:
1. tc,i values as defined above. We required one such value to be
>0.5, since with this cutoff, a TCwill be preferentially expressed
only in one tissue.
2. The assessment whether this over- or underrepresentation was
significant, that is, unlikely to have arisen from random sam-
pling from the underlying tags. This can be expressed as a bi-
nomial overrepresentation test. We required that the TC in
question presented a P-value <0.05 in a one-tailed binomial
overrepresentation test (R function: binom.test).
3. We only assessed core promoters nc > 30 TPMs. The tag number
constraint is not strictly necessary; we introduced the addi-
tional constraint to reduce the number of statistical tests (as
tests with few tags will always be insignificant) and to focus on
strong promoters.
Mapping PEPs to genes and introns
PEPs were considered to belong to a gene if they had at least one
tag on the same strand within the boundary of its transcript (using
the RIKEN cDNA database) including a 50-bp slack at the 59-end of
the gene. If a PEP had no such overlap, it was considered inter-
genic. PEPs belonging to genes were further divided into exonic if
the PEP overlaps with an exon, or otherwise as intronic.
Domain annotation and PEPs
Domains were annotated using RIKEN cDNA annotation (corre-
sponding to Interpro domain locations). To determine whether
transcription initiation at the hippocampus PEPs changed the
domain product, we used the genemappings from above. Thenwe
checkedwhether any domain in a gene containing a hippocampus
PEP was upstream of this PEP and downstream from the annotated
transcription start site. Usage of this PEP would result in the do-
main being lost and consequently in a different protein product.
TFBS overrepresentation analysis
We searched all sequence sets with the JASPAR matrices (Vlieghe
et al. 2006) using the ASAP tool (Marstrand et al. 2008) with the
following setting: uniform background model, a pseudo-count of
1, and threshold value of 0.7 relative to the matrix-specific scoring
range. For all matrices, we calculated a P-value representing the
overrepresentation using the binomial test as described in van
Helden et al. (1998). For the tables, the P-value threshold is <0.01.
As a background set, we used all core promoters withmore than 30
TPM.
In situ comparison
For comparing expression and tissue preference of transcription
factors between CAGE and in situ experiments available from the
Allen Brain Atlas (Lein et al. 2007), we calculated the hippocampus
strength versus tissue preference T for each transcription factor
gene (using the RIKEN TF database [Kanamori et al. 2004]):
T =
+
c
nc;hippocampus
+
c
+
i
nc;i
where we sum over all TCs c that are within the boundary of the
gene of interest, and all the brain tissues i. nc,i is the TPM count for
respective TC and tissue. This was then visually compared with
corresponding in situ images, downloaded from http://www.
brain-map.org/.
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